JP2008513035A5 - - Google Patents

Download PDF

Info

Publication number
JP2008513035A5
JP2008513035A5 JP2007532893A JP2007532893A JP2008513035A5 JP 2008513035 A5 JP2008513035 A5 JP 2008513035A5 JP 2007532893 A JP2007532893 A JP 2007532893A JP 2007532893 A JP2007532893 A JP 2007532893A JP 2008513035 A5 JP2008513035 A5 JP 2008513035A5
Authority
JP
Japan
Prior art keywords
polypeptide
seq
modified virus
virus
particle according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007532893A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008513035A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2005/054721 external-priority patent/WO2006032674A1/en
Publication of JP2008513035A publication Critical patent/JP2008513035A/ja
Publication of JP2008513035A5 publication Critical patent/JP2008513035A5/ja
Pending legal-status Critical Current

Links

JP2007532893A 2004-09-21 2005-09-21 Ａｐ２０５のコートタンパク質と抗原性ポリペプチドとの融合タンパク質を含んでなるウイルス粒子 Pending JP2008513035A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US61130804P 2004-09-21 2004-09-21
EP05105229 2005-06-14
PCT/EP2005/054721 WO2006032674A1 (en) 2004-09-21 2005-09-21 Virus-like particles comprising a fusion protein of the coat protein of ap205 and an antigenic polypeptide

Publications (2)

Publication Number Publication Date
JP2008513035A JP2008513035A (ja) 2008-05-01
JP2008513035A5 true JP2008513035A5 (https=) 2009-06-18

Family

ID=46307785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007532893A Pending JP2008513035A (ja) 2004-09-21 2005-09-21 Ａｐ２０５のコートタンパク質と抗原性ポリペプチドとの融合タンパク質を含んでなるウイルス粒子

Country Status (10)

Country Link
US (1) US20080292652A1 (https=)
EP (1) EP1791870A1 (https=)
JP (1) JP2008513035A (https=)
AU (1) AU2005286475A1 (https=)
BR (1) BRPI0516953A (https=)
CA (1) CA2580208A1 (https=)
MX (1) MX2007003171A (https=)
NZ (1) NZ554387A (https=)
RU (1) RU2409667C2 (https=)
WO (1) WO2006032674A1 (https=)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
DE60234375D1 (de) * 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
EP2338510A1 (en) * 2002-07-19 2011-06-29 Novartis Pharma AG Vaccine compositions containing amyloid beta1-6 antigen arrays
CN1753687A (zh) 2002-10-29 2006-03-29 科勒制药集团股份有限公司 Cpg寡核苷酸在治疗丙型肝炎病毒感染中的应用
AU2004224761A1 (en) 2003-03-26 2004-10-07 Cytos Biotechnology Ag HIV-peptide-carrier-conjugates
US7959928B2 (en) 2004-10-05 2011-06-14 Cytos Biotechnology Ag VLP-antigen conjugates and their uses as vaccines
AU2005298689A1 (en) 2004-10-25 2006-05-04 Cytos Biotechnology Ag Gastric inhibitory polypeptide (GIP) antigen arrays and uses thereof
CN101193654A (zh) * 2005-06-14 2008-06-04 赛托斯生物技术公司 抗原偶联物及其用途
ES2310062B1 (es) 2005-07-15 2009-11-13 Bionostra, S.L. Particulas pseudovirales vacias quimericas derivadas del virus causante de la enfermedad de la bursitis infecciosa (ibdv), procedimiento de obtencion y aplicaciones.
NZ566971A (en) 2005-09-28 2011-06-30 Cytos Biotechnology Ag Vaccine containing a virus like particle linked with an interleukin-1 molecule
CA2636139A1 (en) * 2005-12-14 2007-06-21 Cytos Biotechnology Ag Immunostimulatory nucleic acid packaged particles for the treatment of hypersensitivity
AT503690A1 (de) * 2006-06-09 2007-12-15 Biomay Ag Hypoallergene moleküle
US8541559B2 (en) 2006-06-12 2013-09-24 Cytos Biotechnology Ag Process for producing aggregated oligonucleotides
AU2013204383B2 (en) * 2006-06-12 2016-09-22 Kuros Us Llc Processes for packaging oligonucleotides into virus-like particles of RNA bacteriophages
US20090142362A1 (en) * 2006-11-06 2009-06-04 Avant Immunotherapeutics, Inc. Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
US8586728B2 (en) 2006-12-12 2013-11-19 Cytos Biotechnology Ag Oligonucleotides containing high concentrations of guanine monomers
EP2121007A1 (en) * 2006-12-21 2009-11-25 Cytos Biotechnology AG Circular ccr5 peptide conjugates and uses thereof
CN101245110B (zh) * 2007-02-16 2010-09-15 鲁南制药集团股份有限公司 重组中性粒细胞抑制因子和水蛭原嵌合蛋白及其药物组合物
US20110262472A1 (en) * 2008-04-22 2011-10-27 Cytos Biotechnology Ag Vaccine compositions for the treatment of dengue fever and uses thereof
WO2010122164A1 (en) 2009-04-23 2010-10-28 Cytos Biotechnology Ag VIRUS-LIKE PARTICLES OF BACTERIOPHAGE φCB5
NZ596058A (en) * 2009-04-30 2013-08-30 Cytos Biotechnology Ag Influenza hemagglutinin compositions and uses thereof
CA2793580A1 (en) * 2010-03-29 2011-10-06 Novartis Ag Composition comprising the amyloid beta 1-6 peptide coupled to a virus-like particle and an adjuvant
GB201121571D0 (en) * 2011-12-15 2012-01-25 Astrimmune Ltd Compounds and uses thereof
CN104011080B (zh) 2011-12-22 2017-10-20 弗·哈夫曼-拉罗切有限公司 用于真核细胞的全长抗体展示系统及其用途
KR102181258B1 (ko) * 2012-02-16 2020-11-20 브이엘피 테라퓨틱스 엘엘씨 바이러스 유사 입자 조성물
ES2736500T3 (es) 2014-06-18 2020-01-02 Morphosys Ag Proteínas de fusión y usos de las mismas
CN104255335B (zh) * 2014-08-24 2016-08-31 苗建军 一种吊放蔓用钳
RU2568872C1 (ru) * 2014-10-15 2015-11-20 Игорь Геннадьевич Сивов Лекарственное средство для лечения вирусного гепатита с
MA40824A (fr) * 2014-10-22 2017-08-29 Saiba Gmbh Particules de cmv de type virus modifié
WO2016112921A1 (en) 2015-01-15 2016-07-21 University Of Copenhagen Virus-like particle with efficient epitope display
EP3368068B1 (en) 2015-10-30 2020-11-18 University of Copenhagen Virus like particle with efficient epitope display
EP3389693A4 (en) 2015-12-18 2019-08-21 Agilvax, Inc. COMPOSITIONS AND METHODS RELATED TO XCT PEPTIDES
BR112018071965A2 (pt) * 2016-04-27 2019-03-06 Benchmark Animal Health Ltd tratamento da dermatite atópica canina
CN112500456B (zh) * 2020-12-02 2022-10-28 深圳赫兹生命科学技术有限公司 一种去势ap205病毒样颗粒亚单位疫苗
US20220241400A1 (en) * 2021-02-02 2022-08-04 Provaxus, Inc. Immunomodulation platform and methods of use
WO2022218928A1 (en) 2021-04-12 2022-10-20 Saiba AG Modified virus-like particles of bacteriophage ap205
US20240156937A1 (en) * 2021-04-23 2024-05-16 Unm Rainforest Innovations Baceriophage virus-like particles vaccines for chlamydia trachomatis infections
CN114933639B (zh) * 2022-05-05 2023-12-29 中国农业科学院兰州兽医研究所 非洲猪瘟病毒p72N抗原表位蛋白及其制备方法和用途
CN115819623A (zh) * 2022-12-12 2023-03-21 长春百克生物科技股份公司 一种重组病毒样颗粒疫苗组合物的制备及应用
CN118684781A (zh) * 2023-03-21 2024-09-24 深圳赫兹生命科学技术有限公司 GnRH-VLP重组去势疫苗及其制备方法
EP4737572A1 (en) * 2023-06-29 2026-05-06 Shenzhen Herz Life Science Technology Co., Ltd Preparation method for castrating ap205 virus-like particle subunit vaccine

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020193565A1 (en) * 1998-03-27 2002-12-19 Stanley Margaret Anne Antigen preparation and use
WO2003031466A2 (en) * 2001-10-05 2003-04-17 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
US7264810B2 (en) * 2001-01-19 2007-09-04 Cytos Biotechnology Ag Molecular antigen array
US7128911B2 (en) * 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
CA2492823A1 (en) * 2001-09-14 2003-03-27 Cytos Biotechnology Ag In vivo activation of antigen presenting cells for enhancement of immune responses induced by virus like particles
DE60234375D1 (de) * 2001-09-14 2009-12-24 Cytos Biotechnology Ag VERPACKUNG VON IMMUNSTIMULIERENDEM CpG IN VIRUSÄHNLICHEN PARTIKELN: HERSTELLUNGSVERFAHREN UND VERWENDUNG
ES2316628T3 (es) * 2001-11-07 2009-04-16 Cytos Biotechnology Ag Disposicion ordenada de antigenos que comprende rankl para el tratamiento de enfermedades oseas.
AU2002363382B2 (en) * 2001-11-07 2007-07-19 Cytos Biotechnology Ag Antigen arrays presenting IL-5, IL-3 or eotaxin for treatment of allergic eosinophilic diseases
BR0311995A (pt) * 2002-06-20 2005-04-05 Cytos Biotechnology Ag Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso
ES2431963T3 (es) * 2002-07-05 2013-11-28 Folia Biotech Inc. Partícula viral adyuvante
US7138252B2 (en) * 2002-07-17 2006-11-21 Cytos Biotechnology Ag Molecular antigen arrays

Similar Documents

Publication Publication Date Title
JP2008513035A5 (https=)
RU2409667C2 (ru) Вирусоподобные частицы, включающие гибридный белок белка оболочки бактериофага ар205 и антигенного полипептида
RU2003125363A (ru) Молекулярный массив антигенов
RU2005104235A (ru) Молекулярные массивы антигенов
AU2015335027B2 (en) Modified virus-like particles of CMV
Al-Barwani et al. Antigen delivery by virus-like particles for immunotherapeutic vaccination
KR20070058426A (ko) 비-인간 ｔｎｆ-펩티드의 담체 콘쥬게이트의 의학적 용도
AU2002362696B2 (en) Angiotensin peptide-carrier conjugates and uses thereof
JP7623282B2 (ja) 融合によって修飾されたｃｍｖのウイルス様粒子
CA2672826A1 (en) Circular ccr5 peptide conjugates and uses thereof
JP2024504566A (ja) 核酸ワクチン
US20080019991A1 (en) Carrier Conjugates Of Tnf-Peptides
EP4323397A1 (en) Modified virus-like particles of bacteriophage ap205
RU2417793C2 (ru) Конъюгаты впч-антиген и их применение в качестве вакцин
RU2845190C2 (ru) Вирусоподобные частицы cmv, модифицированные путем слияния
WO2024091589A1 (en) Malaria immunogen and methods for using same
Toebes et al. Preclinical development of highly effective and safe DNA vaccines directed against HPV 16 E6 and E7